[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-353045-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-353045-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","subclonal-cateninyap-signaling-heterogeneity-accelerates-ovarian-cancer-metastasis-through-a-senescence-associated-secretory-phenotype","Subclonal β-catenin/YAP signaling heterogeneity accelerates ovarian cancer metastasis through a senescence-associated secretory phenotype","","Intratumoral heterogeneity in metastatic cancers complicates treatment because tumor subclones show distinct drug sensitivities and metastatic capacities, yet the mechanisms of subclonal interaction remain unclear. Using an isogenic ovarian cancer cell pair with low- and high-β-catenin signaling, co-engraftment enhances peritoneal metastasis and reveals mosaic β-catenin expression. Both the non-metastatic subclone and β-catenin–deficient high-metastatic cells develop a Hippo/YAP-driven SASP that is suppressed by β-catenin and promotes dissemination via paracrine signaling. Mixed tumors respond more to the senolytic fisetin and YAP inhibition, reducing metastatic burden.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/subclonal-cateninyap-signaling-heterogeneity-accelerates-ovarian-cancer-metastasis-through-a-senescence-associated-secretory-phenotype/353045/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/subclonal-cateninyap-signaling-heterogeneity-accelerates-ovarian-cancer-metastasis-through-a-senescence-associated-secretory-phenotype/353045.png","ImageObject",300,407,{"name":42,"@type":43},"Dipper","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-19","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How does β-catenin heterogeneity influence ovarian cancer metastasis in this study?","Question",{"text":63,"@type":64},"Spatially heterogeneous β-catenin expression creates functionally interdependent subclones. Co-engrafting low- and high-β-catenin cells increases peritoneal metastasis compared with either subclone alone.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What is the role of senescence-associated secretory phenotype (SASP) here?",{"text":68,"@type":64},"Both the non-metastatic subclone and β-catenin–knockout high-metastatic cells show a SASP. This SASP facilitates metastatic dissemination through paracrine signaling.",{"name":70,"@type":61,"acceptedAnswer":71},"Why are mixed tumors more sensitive to fisetin and YAP inhibition?",{"text":72,"@type":64},"In vivo mixed tumors exhibit greater susceptibility to fisetin, a senolytic agent, and to YAP inhibition. These treatments markedly reduce metastatic burden by targeting the senescence-like subclonal interaction mechanism.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},353045,1790383761,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":113,"preview_page_count":33,"preview_urls":145},1374404997633,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","[www.nature.com/cddis](www.nature.com/cddis)  \nARTICLE OPEN   \nSubclonal β-catenin/YAP signaling heterogeneity accelerates ovarian cancer metastasis through a senescence-associated secretory phenotype  \nSally K. Y.  \nAlice S. T.  \nTo1,2,5, Yibin Yang1,5, Zeyu Shi1,2,5, Katie S. W. Fung1,2, Sook Ling Lai 1, Joshua J. X. Li3, Philip P. C. Ip 3 and  \n 1,4 ✉  \nWong   \n© The Author(s) 2026  \n\n|  |  |  |\n| --- | --- | --- |\n|  | Intratumoral heterogeneity in metastatic cancers complicates effective treatment, as distinct tumor subclones display varying drug sensitivities and metastatic capabilities, interacting through mechanisms that remain poorly understood. In this study, we utilized an isogenic ovarian cancer cell pair distinguished by differential β-catenin signaling: non-metastatic (NM) cells with low β-cateninand highly metastatic (HM) cells with elevated β-catenin signaling. Co-engrafting NM and HM cells synergistically enhances peritoneal metastasis compared to either subclone alone. Immunohistochemical analysis revealed a mosaic β-catenin expression in mixed tumors, recapitulating the heterogeneity observed in clinical ovarian cancer cases. Notably, both NM cells and β-cateninknockout HM cells exhibited an intrinsic senescence-associated secretory phenotype (SASP), mechanistically driven by Hippo/YAP signaling, which was suppressed by β-catenin in HM cells. This phenotype in turn facilitated the metastatic dissemination of β-catenin-high subclones through paracrine signaling. Importantly, mixed in vivo tumors were more susceptible to treatment with ﬁsetin, a senolytic agent, and YAP inhibition, leading to marked reduction in metastatic burden. Overall, our ﬁndings demonstrate the pre-existence of senescence-like tumor cells in untreated conditions and reveal a novel cooperative mechanism in which β-catenin heterogeneity facilitates ovarian cancer progression through SASP-mediated subclonal interactions. These results provide a basis for targeted therapeutic strategies to disrupt intratumoral communication and improve treatment outcomes in metastatic |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  | ovarian cancer. |  |\n|  |  |  |\n|  |  |  |\n|  | Cell Death and Disease (2026)17:539; [https://doi.org/10.1038/s41419-026-08737-7](https://doi.org/10.1038/s41419-026-08737-7) |  |\n|  |  |  |\n\nMAIN  \nIntratumoral heterogeneity, characterized by the co-existence of phenotypically and functionally distinct subpopulations within a single neoplastic lesion, represents a fundamental challenge in cancer treatment. Numerous studies have demonstrated that this diversity can drive rapid tumor progression, treatment resistance, and metastasis, presenting a signiﬁcant challenge for the development of effective cancer therapies and limiting reproducible prognostic classiﬁcations [1, 2] . Despite widespread recognition of its clinical importance, our understanding of how heterogeneous subclones interact to promote malignancy remains limited. The majority of cancer research has focused on studying the dominant tumor subclone which are capable of evading clinical interventions and seeding new metastatic foci, often neglecting the contributions and implications of minor subpopulations. While genomic studies have mapped clonal architecture, they often overlook the dynamic functional relationships and interdependency between subpopulations that collectively drive tumor progression [3, 4]. These relationships are crucial for identifying vulnerabilities that can be exploited for therapeutic  \nbeneﬁt. Recent evidence suggests that tumor subclones do not merely compete but can actively cooperate, playing a direct functional role rather than just providing a reservoir of variants that allows rapid response [5–7] . It is also important to note that subclonal interaction could result in group behaviors and the emergence of new capabilities that cannot be","cbCaihbVOU6TiBc0","https://ap.wps.com/l/cbCaihbVOU6TiBc0","pdf",4584185,12,"English","# Intratumoral heterogeneity and clinical challenge\n## Ovarian cancer progression and need for actionable strategies\n## β-catenin heterogeneity and prior findings","[{\"question\":\"How does β-catenin heterogeneity influence ovarian cancer metastasis in this study?\",\"answer\":\"Spatially heterogeneous β-catenin expression creates functionally interdependent subclones. Co-engrafting low- and high-β-catenin cells increases peritoneal metastasis compared with either subclone alone.\"},{\"question\":\"What is the role of senescence-associated secretory phenotype (SASP) here?\",\"answer\":\"Both the non-metastatic subclone and β-catenin–knockout high-metastatic cells show a SASP. This SASP facilitates metastatic dissemination through paracrine signaling.\"},{\"question\":\"Why are mixed tumors more sensitive to fisetin and YAP inhibition?\",\"answer\":\"In vivo mixed tumors exhibit greater susceptibility to fisetin, a senolytic agent, and to YAP inhibition. These treatments markedly reduce metastatic burden by targeting the senescence-like subclonal interaction mechanism.\"}]","Subclonal β-catenin/YAP signaling heterogeneity accelerates ovarian cancer metastasis through a senescence-associated secretory phenotype | PDF",1790102714,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e56b750358fc645d404f6c3f6a94c01f.webp",983,1305,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5b0d9bfcabbee2fe2915b2c1a4138b38.webp",982,1304,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/53323cf1cb4d43243154180a20c3ea85.webp",981,1303,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c1d27fe07c55f8a1d3c0b9a3c27a4713.webp",980,1301]